Please login to the form below

Not currently logged in
Email:
Password:

Former Roche development head joins Asana advisory board

Dr Kapil Dhingra also brings experience from Lilly

Asana BioSciences Dr Kapil DhingraAsana BioSciences has appointed former head of Roche oncology clinical development Dr Kapil Dhingra to its oncology scientific advisory board.

Dr Dhingra served at Roche from 1999 to 2008, most recently as vice president, head of the Swiss pharma company's oncology disease biology leadership team and head of oncology clinical development.

Prior to that he worked at Lilly as a clinical research physician having previously served at the faculty of M.D. Anderson Cancer Center in Houston, Texas, where he pursued laboratory and clinical cancer research.

Dr Sandeep Gupta, founder, president and CEO of New Jersey-based Asana Biosciences, said: “We welcome Dr. Dhingra to our oncology scientific advisory board. His expertise, proven track record and strategic insights will be great assets to Asana.

I look forward to working closely with him and other SAB members in advancing our robust and differentiated oncology pipeline further into clinical development.”

The founder of KAPital Consulting, Dr Dhingra currently serves on the boards of Exosome Diagnostics as chairman of the board, Advanced Accelerator Applications, Five Prime and Autolus.

11th January 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Spotlight interview: 15 minutes on insights and market research in pharma
Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma...
WHITE PAPER: The increasing importance of clinical trial marketing advertising in patient recruitment
Learn why advertising is more important than ever in clinical studies...
The 'winner takes all' pricing game
Tendering has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s....

Infographics